YK
Yusuke Kumaki
About Yusuke Kumaki
Data last updated:
Yusuke Kumaki is a Director at Skites Pharma Private Limited (since 2025), Director at S Kant India Private Limited (since 2025) and Director at Ashok Gnxt Pharma Private Limited (since 2025). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹769 Cr; the largest is Skites Pharma Private Limited at ₹661 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skites Pharma Private Limited U24304MH2017PTC292537 | Director | 27 Jun 2025 | 2017 | ₹661 Cr (FY 2025) | Active |
 S Kant India Private Limited U24290MH2023PTC397388 | Director | 27 Jun 2025 | 2023 | ₹73.61 Cr (FY 2025) | Active |
| Ashok Gnxt Pharma Private Limited U51909GJ2019PTC107421 | Director | 27 Jun 2025 | 2019 | ₹34.06 Cr (FY 2025) | Active |
Board colleagues of Yusuke Kumaki
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahesh Kantilal Shah | 00506695 | Skites Pharma Private Limited , S Kant India Private Limited and 1 more | Director |
| Rohan Mahesh Shah | 02867201 | Skites Pharma Private Limited , S Kant India Private Limited and 1 more | Director |
| Samir Jayantilal Shah | 00157396 | Skites Pharma Private Limited , S Kant India Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yusuke Kumaki
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yusuke Kumaki
Yusuke Kumaki currently holds 3 directorships: Skites Pharma Private Limited (Director, since 27 Jun 2025, revenue ₹661 Cr (FY 2025)); S Kant India Private Limited (Director, since 27 Jun 2025, revenue ₹73.61 Cr (FY 2025)); Ashok Gnxt Pharma Private Limited (Director, since 27 Jun 2025, revenue ₹34.06 Cr (FY 2025)).
Yusuke Kumaki was first appointed on 27 Jun 2025 as Director at Skites Pharma Private Limited.
The 3 current companies of Yusuke Kumaki that report revenue have a combined latest revenue of ₹769 Cr: Skites Pharma Private Limited ₹661 Cr (FY 2025); S Kant India Private Limited ₹73.61 Cr (FY 2025); Ashok Gnxt Pharma Private Limited ₹34.06 Cr (FY 2025).
The current boards of Yusuke Kumaki's companies include Mahesh Kantilal Shah (Skites Pharma Private Limited), Rohan Mahesh Shah (Skites Pharma Private Limited), Samir Jayantilal Shah (Skites Pharma Private Limited).